Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

T2 Biosystems (TTOO)

T2 Biosystems Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TTOO
DateTimeSourceHeadlineSymbolCompany
08/05/202400:46Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TTOOT2 Biosystems Inc
07/05/202421:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
07/05/202421:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
07/05/202414:00GlobeNewswire Inc.T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme DiseaseNASDAQ:TTOOT2 Biosystems Inc
06/05/202422:27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:TTOOT2 Biosystems Inc
06/05/202422:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
06/05/202422:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTOOT2 Biosystems Inc
06/05/202421:34GlobeNewswire Inc.T2 Biosystems Announces First Quarter 2024 Financial ResultsNASDAQ:TTOOT2 Biosystems Inc
06/05/202421:34GlobeNewswire Inc.T2 Biosystems Announces Commercial Expansion Through Middle East DistributorNASDAQ:TTOOT2 Biosystems Inc
06/05/202421:29GlobeNewswire Inc.T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into EquityNASDAQ:TTOOT2 Biosystems Inc
06/05/202412:48Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:TTOOT2 Biosystems Inc
24/04/202414:00GlobeNewswire Inc.T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024NASDAQ:TTOOT2 Biosystems Inc
11/04/202421:05GlobeNewswire Inc.T2 Biosystems Shareholders Vote for CRG Debt Conversion into EquityNASDAQ:TTOOT2 Biosystems Inc
28/03/202413:00GlobeNewswire Inc.T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.NASDAQ:TTOOT2 Biosystems Inc
20/03/202411:30GlobeNewswire Inc.T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
19/03/202413:00GlobeNewswire Inc.T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
18/03/202413:00GlobeNewswire Inc.T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance PanelNASDAQ:TTOOT2 Biosystems Inc
12/03/202413:00GlobeNewswire Inc.T2 Biosystems Receives Extension to Comply with Nasdaq Listing RequirementNASDAQ:TTOOT2 Biosystems Inc
04/03/202421:34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTOOT2 Biosystems Inc
27/02/202421:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
27/02/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
27/02/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
20/02/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
20/02/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
20/02/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
20/02/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
16/02/202422:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
16/02/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
15/02/202421:49Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTOOT2 Biosystems Inc
15/02/202421:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
 Showing the most relevant articles for your search:NASDAQ:TTOO